A team of University of Michigan Rogel Cancer Center researchers have received a $3.07 million grant from the National Cancer Institute to develop a model for long-term surveillance and care of younger adults treated for colorectal cancer.
Michelle Kim, M.D., associate professor of radiation oncology at Michigan Medicine, has received a Research Specialist Award from the National Cancer Institute to pursue clinical research efforts at the University of Michigan Rogel Cancer Center and nationally. Kim’s focus is on clinical research for central nervous system (CNS) tumors.
Rogel Cancer Center faculty and trainees will lead over two dozen presentations, posters and moderated sessions at the American Association for Cancer Research annual meeting. This year’s meeting will be held in-person. View the schedule of presentations.
The University of Michigan Rogel Cancer Center has been re-accredited by the Commission on Cancer, a quality program of the American College of Surgeons. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care. The Rogel Cancer Center was first accredited by CoC in 1932, making it one of the first cancer programs to receive accreditation.
The Rogel Cancer Center is partnering with the Institute for Healthcare Policy and Innovation to help teams translate research into policy. The collaboration offers a cancer-specific opportunity under IHPI’s Policy Sprints program, which launched in 2018 to provide policymakers and stakeholders with timely and rigorous evidence to inform health policy or practice at the local, state, national, or global levels.
Maria G. Castro, Ph.D., R. C. Schneider Collegiate Professor of Neurosurgery and professor of cell and developmental biology at the University of Michigan, was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
MENU
